% | $
Quotes you view appear here for quick access.

Isis Pharmaceuticals, Inc. Message Board

  • dinepat203 dinepat203 Dec 11, 2012 6:20 AM Flag

    ISIS-BIIB Deal - $71M upfront & excess of $1.1Billion from Milestone...Remind U this 3rd major deal 2012

    iogen IDEC (NASDAQ:BIIB), apparently quite impressed with the tech at Isis Pharmaceuticals (NASDAQ:ISIS), has made a third deal with the latter in very short order, paying $30 million upfront and pledging as much as $200 million more in milestones for each of three new programs targeted at neurological diseases and neuromuscular disorders. In all, Biogen has now paid Isis $71 million in upfront payments and and is committed to in excess of $1.1 billion in potential milestones.

    Sentiment: Strong Buy

57.560.00(0.00%)Dec 21 4:00 PMEST